CD38, BCL-2, PD-1, and PD-1L expression in nodal peripheral T-cell lymphoma: Possible biomarkers for novel targeted therapies?

Am J Hematol. 2017 Jan;92(1):E1-E2. doi: 10.1002/ajh.24571. Epub 2016 Nov 10.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • ADP-ribosyl Cyclase 1 / biosynthesis*
  • B7-H1 Antigen / biosynthesis*
  • Drug Delivery Systems / methods
  • Female
  • Gene Expression Regulation, Neoplastic*
  • Humans
  • Lymphoma, T-Cell, Peripheral / drug therapy
  • Lymphoma, T-Cell, Peripheral / metabolism*
  • Lymphoma, T-Cell, Peripheral / pathology
  • Male
  • Membrane Glycoproteins / biosynthesis*
  • Programmed Cell Death 1 Receptor / biosynthesis*
  • Proto-Oncogene Proteins c-bcl-2 / biosynthesis*

Substances

  • B7-H1 Antigen
  • BCL2 protein, human
  • CD274 protein, human
  • Membrane Glycoproteins
  • PDCD1 protein, human
  • Programmed Cell Death 1 Receptor
  • Proto-Oncogene Proteins c-bcl-2
  • CD38 protein, human
  • ADP-ribosyl Cyclase 1